The PPT1 was identified by photoaffinity pulldown as a target of a chloroquine derivative preventing lysosomes acidification and reducing melanoma cells viability and tumor growth in vivo,92 and was subsequently involved in HCC resistance to the kinase inhibitor sorafenib.93 The gene discussed is PPT1; the disease is neoplasm.